04/06/2026
🧠💔 Brain cancer research is making progress. The problem isn’t a lack of ideas. It’s a lack of sustained funding.
Researchers are screening thousands of drugs, identifying promising new treatments for glioblastoma, discovering powerful drug combinations, and developing innovative ways to deliver therapies directly to brain tumours.
The science is moving forward.
But every time funding runs out, projects stall. Teams are broken up. Momentum is lost. Years of work can end up sitting on a shelf, waiting for investment that may never come.
For people diagnosed with glioblastoma, time is something they don’t have. Survival rates have barely improved in decades, despite researchers uncovering new opportunities that could lead to better treatments.
Brain cancer remains one of the deadliest cancers, yet it continues to receive a fraction of the funding given to many other major cancers.
We don’t need to start from scratch. We need governments, funders and decision-makers to make brain cancer research a priority and provide the long-term support needed to take discoveries from the laboratory to patients.
The breakthroughs are there.
What’s missing is the commitment to see them through.
